Fortress Biotech Inc (FBIO)
1.605
+0.04
(+2.23%)
USD |
NASDAQ |
Nov 22, 15:36
Fortress Biotech Price to Book Value: 2.094 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.049 |
| November 20, 2024 | 2.049 |
| November 19, 2024 | 2.075 |
| November 18, 2024 | 1.931 |
| November 15, 2024 | 1.866 |
| November 14, 2024 | 2.049 |
| November 13, 2024 | 2.153 |
| November 12, 2024 | 2.218 |
| November 11, 2024 | 2.297 |
| November 08, 2024 | 2.230 |
| November 07, 2024 | 2.243 |
| November 06, 2024 | 2.295 |
| November 05, 2024 | 2.301 |
| November 04, 2024 | 2.256 |
| November 01, 2024 | 2.478 |
| October 31, 2024 | 2.478 |
| October 30, 2024 | 2.530 |
| October 29, 2024 | 2.634 |
| October 28, 2024 | 2.634 |
| October 25, 2024 | 2.412 |
| October 24, 2024 | 2.256 |
| October 23, 2024 | 2.321 |
| October 22, 2024 | 2.360 |
| October 21, 2024 | 2.321 |
| October 18, 2024 | 2.386 |
| Date | Value |
|---|---|
| October 17, 2024 | 2.360 |
| October 16, 2024 | 2.282 |
| October 15, 2024 | 2.243 |
| October 14, 2024 | 2.191 |
| October 11, 2024 | 2.125 |
| October 10, 2024 | 2.060 |
| October 09, 2024 | 2.060 |
| October 08, 2024 | 1.995 |
| October 07, 2024 | 2.073 |
| October 04, 2024 | 2.125 |
| October 03, 2024 | 2.099 |
| October 02, 2024 | 2.047 |
| October 01, 2024 | 1.865 |
| September 30, 2024 | 1.884 |
| September 27, 2024 | 2.298 |
| September 26, 2024 | 2.236 |
| September 25, 2024 | 2.174 |
| September 24, 2024 | 2.143 |
| September 23, 2024 | 2.204 |
| September 20, 2024 | 1.911 |
| September 19, 2024 | 2.352 |
| September 18, 2024 | 2.454 |
| September 17, 2024 | 2.451 |
| September 16, 2024 | 2.476 |
| September 13, 2024 | 2.514 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7027
Minimum
Nov 10 2023
8.359
Maximum
Feb 14 2020
2.868
Average
2.518
Median
Nov 25 2020
Price to Book Value Benchmarks
| Journey Medical Corp | 10.43 |
| Checkpoint Therapeutics Inc | -- |
| Avenue Therapeutics Inc | 1.531 |
| Mustang Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.135 |
Price to Book Value Related Metrics
| PS Ratio | 0.3134 |
| PEG Ratio | -0.0394 |
| Price | 1.605 |
| Earnings Yield | -826.8% |
| Market Cap | 44.31M |
| PEGY Ratio | -0.0394 |